Minimal Determinant Expressed by a Recombinant Vaccinia Virus Elicits Therapeutic Antitumor Cytolytic T Lymphocyte Responses

Anticancer vaccine strategies can now target intracellular antigens that are involved in the process of malignant transformation, such as oncogene products or mutated tumor suppressor genes. Fragments of these antigens, generally 8–10 amino acids in length and complexed with MHC class I molecules, c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: McCabe, Barbra Jill, Irvine, Kari R., Nishimura, Michael I., Yang, James C., Spiess, Paul J., Shulman, Eliza P., Rosenberg, Steven A., Restifo, Nicholas P.
Formato: Artigo
Lenguaje:Inglês
Publicado: 1995
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2248453/
https://ncbi.nlm.nih.gov/pubmed/7536130
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares